This observational study is evaluating a new scoring system called CAGIB. This score helps doctors predict the risk of death in the hospital for patients with liver cirrhosis (scarring of the liver) who experience acute gastrointestinal bleeding (sudden bleeding in the digestive tract). Researchers want to see if the CAGIB score is better than or as good as two other common scores, Child-Pugh and MELD, at predicting this outcome. You might be able to join if you are at least 18 years old, have liver cirrhosis, and are experiencing acute gastrointestinal bleeding. The study aims to enroll 3000 participants. The main goal is to see how well these scores predict death in the hospital, from when you are admitted until you are discharged (an average of 1-6 weeks). The current recruitment status is unclear.

Study design

This is an observational study, meaning researchers will collect information without giving any specific treatments. It aims to include 3000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will track mortality from admission to discharge, which is an average of 1-6 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.